verified COP 5,1 · D1 • database Scopus / SJR & Web of Science indexed

Netherlands · Elsevier B.V.

workspace_premium D1 Top 10% — Pharmacology (medical) lock_open Open Access

European Neuropsychopharmacology

European Neuropsychopharmacology is a journal indexed in SJR in Pharmacology and Neurology (clinical) with an H index of 136. It has a COP Index of 5,1 (best band D1). It is published in English. It has a COP Index of 5,1.

European Neuropsychopharmacology focuses its scope in these topics and keywords: functioning, dopamine, calendar, system, response, receptor, patients, neuronal, monoamine, early, ...

ISSN: 0924-977X

Publisher: Elsevier B.V.

Category: Pharmacology

Indexation: verifiedScopus / SJR verifiedWeb of Science

open_in_new Portal NPD menu_book Guidelines NPD

schedule CountryOfPapers database fields

COP Index trending_up

5,1 D1 Top 10%

19 of 216 journals in Pharmacology (medical)

H-index · SJR 136 · 1,934

Acceptance rate pie_chart

23% Selective

Source Acceptance_Rate

Time to publication hourglass_top

NPD

Field NPD

Publication cost (APC) payments

NPD Open Access

Non-OA path 0 €

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

COP Index

5,1

D1 Top 10%

SJR Impact

1,934

H-index

136

Docs (year)

150

Docs 3y

433

Total refs

5777

Cites 3y

1941

Citable 3y

289

Cites/Doc 2y

4.89

Ref/Doc

38.51

Immediate OA

—

Embargoed OA

NPD

Non OA / Submission

0 €

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Developmental processes and immunology in schizophrenia

Vitamin E inhibits cellular accumulation of desipramine and prevents antidepressant induced beta-adrenoceptor down-regulation in vitro and in vivo

MAO and COMT: basic functions and therapeutic indications

Lymphocyte peripheral benzodiazepine receptor mRNA decreases in obsessive-compulsive disorder

Long-term continuation therapy with the novel antipsychotic olanzapine: A review of the clinical experience

L-5 Critical progress in MAO inhibition in the treatment of mood disorders

Involvement of dynorphin in immobilization stress-induced antinociception in the mouse

Inflammation and anti-inflammatory treatment strategies in Alzheimer's disease

Gabapentin as monotherapy in the treatment of acute mania

Free radical formation level in rabbit brain after experimental cranlocerebral trauma

Effects of low-dose cholecystokinin on respiratory function in healthy volunteers

Effects of calcium channel blockade on intravenous self-administration of ethanol in rats

SHOW MORE ARTICLES

Effect of nicotine on sniffing induced by dopaminergic receptor stimulation

Abnormalities of hypothalamus-pituitary-adrenal axis function and natural killer cell activity in Alzheimer's disease

Comparative efficacy of moclobemide and imipramine on anxiety features in major depression- a meta-analysis of double blind comparative studies against placebo

Combined pharmakotherapy (Tramadon and mianserin) in chronic pain syndrome

Clinico-pharmacokinetic prognosis of prophylactic efficacy of carbamazepine, oxcarbazepine and sodium valproate in affective and schizoaffective disorders

Changes of cerebrospinal fluid monoamine metabolites during long-term antidepressant treatment

Changes in composition of phospholipids and fatty acids in rat brain during aging

Calcium channel blockers prevent memory impairment induced by the beta-blockers acebutolol and metoprolol

Blunted reaction to the citalopram challenge test in patients with major depression

Antagonism of the 5-HT1A receptor stimulus in a conditioned taste aversion procedure

An aminopyrimidine with potent affinity for both dopamine and serotonin reoeptors

Ammonium acetate challenge in experimental chronic hepatic encephalopathy induces a transient increase of brain 5-HT release in vivo

FAQs

European Neuropsychopharmacology has a COP Index of 5,1 (D1), ranked 19 of 216 in Pharmacology (medical). SJR: 1,934.

Immediate OA APC is not available (NPD). Non-OA / submission fee is 0 EUR.

The acceptance rate recorded for European Neuropsychopharmacology is 23%.

European Neuropsychopharmacology

Metrics

Name good journals. Call out predatory ones.

Researcher reviews

Best articles by citations

FAQs

What is the COP Index of European Neuropsychopharmacology?

What is the APC / publication cost?

What is the acceptance rate?